Bio-Rad Laboratories (BIO) Expected to Announce Quarterly Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO) is anticipated to post its quarterly earnings results after the market closes on Thursday, February 13th. Analysts expect Bio-Rad Laboratories to post earnings of $2.86 per share and revenue of $679.75 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Bio-Rad Laboratories Trading Down 4.6 %

Shares of BIO stock opened at $326.36 on Tuesday. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52. The stock’s 50 day simple moving average is $340.91 and its two-hundred day simple moving average is $336.95. Bio-Rad Laboratories has a 1 year low of $262.12 and a 1 year high of $387.99. The company has a market cap of $9.14 billion, a PE ratio of -11.94 and a beta of 0.90.

Analyst Ratings Changes

Several equities research analysts have weighed in on BIO shares. StockNews.com raised Bio-Rad Laboratories from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Citigroup boosted their price objective on Bio-Rad Laboratories from $400.00 to $450.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $481.00 price target on shares of Bio-Rad Laboratories in a research note on Tuesday, January 14th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $394.20.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.